Pre-Clinical Neuroprotective Evidences of Sulforaphane in Alzheimer’s Disease

New Publication


Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease. J Kim. International Journal of Molecular Sciences 22 (6), 2929

(Impact Factor 4.556)


Abstract: https://www.mdpi.com/1422-0067/22/6/2929 PDF Version: https://www.mdpi.com/1422-0067/22/6/2929/pdf